findmyKOL

Adnan Qureshi, MD

Enriched profile

Professor of Neurology and Program Director of the Endovascular Surgical Neuroradiology Fellowship · University of Missouri Columbia School of Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Columbia, MO · Midwest · United StatesSpecialtyNeurologyFocusAcute Ischemic Stroke Management+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceNone verifiedPayments2021–2025NIH fundingNone on fileWhy? →

Adnan Qureshi is Professor of Neurology and Program Director of the Endovascular Surgical Neuroradiology Fellowship at University of Missouri Columbia School of Medicine. OpenAlex indexes 1,770 publications with 45,302 citations (h-index 95); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.

Data verified 12 Oct 2026

Overview

Updated 14 Oct 2026

Adnan Qureshi, M.D., is Professor of Neurology and Program Director of the Endovascular Surgical Neuroradiology Fellowship at University of Missouri Columbia School of Medicine. The public record shows 1,770 publications with 45,302 citations (h-index 95), centered on Acute Ischemic Stroke Management, Intracranial Aneurysms: Treatment and Complications, Cerebrovascular and Carotid Artery Diseases. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 13 companies.

  • Most recent indexed publication: 2026 · Neurology
  • Top research focus: Acute Ischemic Stroke Management
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 13 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Stroke3 trialsHemorrhage3 trialsCerebral Hemorrhage3 trialsHypertension2 trials

Research focus

OpenAlex concept fingerprint
Acute Ischemic Stroke ManagementIntracranial Aneurysms: Treatment and ComplicationsCerebrovascular and Carotid Artery DiseasesIntracerebral and Subarachnoid Hemorrhage ResearchAcute Myocardial Infarction Research

Drugs & molecules

across trials, industry payments and publications
Cleviprexgeneric · ClevidipineClinical trials—Industry payments21Publications—Brilintageneric · TicagrelorClinical trials—Industry payments4Publications—Kengrealgeneric · CangrelorClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Chiesi USA, Inc.Clinical trials—Industry payments21Rapid Medical LtdClinical trials—Industry payments5AstraZeneca Pharmaceuticals LPClinical trials—Industry payments4BTG International Inc.Clinical trials—Industry payments4MicroVention, Inc.Clinical trials—Industry payments3Penumbra, Inc.Clinical trials—Industry payments3Perfuze LimitedClinical trials—Industry payments3Medtronic, Inc.Clinical trials—Industry payments2University of MinnesotaClinical trials2Industry payments—DePuy Synthes Sales Inc.Clinical trials—Industry payments1Imperative Care, IncClinical trials—Industry payments1Medical Device Business Services, Inc.Clinical trials—Industry payments1Stryker CorporationClinical trials—Industry payments1Terumo Medical CorporationClinical trials—Industry payments1University of Missouri-ColumbiaClinical trials1Industry payments—Zeenat Qureshi Stroke InstituteClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,770publications

Distinct works indexed by OpenAlex, matched via ORCID; 51 in PubMed.

45,302citations

Total citations across indexed works.

95h-index

Hirsch index (OpenAlex). i10-index 517.

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
13companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2022)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Blood & clotting

    100%
    P2Y12 inhibitor100%
    Clopidogrel100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Muhammad Fareed K. Suri260Saqib Chaudhry211Ameer E Hassan209Farhan Siddiq192Malik Muhammad Adil169Camilo R. Gomez150Ahmed Malik105Leo Nelson Hopkins97Jawad F. Kirmani97Gustavo Jose Rodriguez93Mushtaq Qureshi84Lee R. Guterman79Shahram Majidi75Wondwossen G. Tekle72Brandi R French71Chun Shing Kwok60José I. Suárez59Iryna Lobanova57Wei Huang57Omar Saeed54Fareed K Suri52Daniel F. Hanley51Afshin A. Divani49Mohammad Rauf Afzal47Nazli A. Janjua45Abutaher M. Yahia44Nauman A. Tariq44Haitham M. Hussein43Muhammad Fawad Ishfaq43Navpreet K. Bains41Mohammad Rauf Chaudhry41Haseeb Rahman40Haralabos Zacharatos39Mustapha A. Ezzeddine37Vishal B. Jani37M. Fareed K. Suri37Iqra Naveed Akhtar37Guido J. Falcone36Kevin Navin Sheth36Rakesh Khatri36

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    backtable.com/shows/vi/contributors/dr-adnan-qureshi

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →backtable.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medifind.com ↗

Editorial & leadership roles

journal and society appointments

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.